ArticleTranslational andrology and urology2024

Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?

Benjamin Lichtbroun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.